Ipca Labs shares drop over 5% on weak Q3 results. What should investors do?

EBITDA before forex declined 15% to Rs 262.82 crore in the third quarter of 2022 from Rs 310.83 crore posted in the same quarter of FY22. EBITDA margin reduced to 16.67% in Q3 FY23 as compared with 21.53% reported in the same period last year